Straumann Group increases stake in Createch to 100%
- Straumann to integrate Createch in its global CADCAM platform
- Createch complements Medentika and etkon, making Straumann a total solution provider for CADCAM prosthetics covering more than 300 implant systems
- Createch to become a global development center thanks to strong innovation capabilities and fast development streams
Basel, 4 July 2018 – The Straumann Group has increased its stake in Createch Medical, a leading provider of high-precision CADCAM dental prosthetics, from 30% to full ownership for a purchase consideration of approximately CHF 14 million. The acquisition enables the Group to make full use of Createch’s expertise, innovation and development capabilities. ¨
Like the Group’s investment in its biomaterials partner botiss medical (announced today in a separate release), this acquisition is a further step in the Group’s strategy to become a total solution provider in tooth replacement and esthetic dentistry.
Marco Gadola , Chief Executive Officer of the Straumann Group, commented: “Createch is renowned for high-precision and tailor-made prosthetic solutions. Its highly advanced technology, expertise in milling and fast development streams have enabled it to pioneer and offer solutions that are beyond the scope of most CADCAM providers. Createch is agile, responsive and forward-looking, which is why it has become a leading player in the sector. It enhances our premium solutions and, together with Medentika, positions the Straumann Group as the total solution provider of CADCAM prosthetic solutions for almost every implant system”.
Partners since 2013
Straumann initial investment, in 2013, was driven by a pressing need for high-end CADCAM frameworks in order to provide a full range of premium edentulous solutions. Createch also offered high-precision prosthetics for competitor implant systems. As the partnership developed, Straumann took over the distribution of Createch’s products outside their domestic market and contributed significantly to expanding their business. With the development of Straumann’s Pro Arch® system and Createch’s extensive range of connections the Group today offers an unparalleled range of implant-based solutions for edentulous patients.
Implant-based prosthetic solutions for edentulous patients:
Createch's hi-end screw-retained frameworks together with Straumann's range of bars and bridges
A global innovation and development centre
Moving forward, the Group intends to unlock Createch’s innovation and development potential by making it a global development centre for screw-retained bars and bridges. Using new technologies, like additive manufacturing and laser sintering, the company will increase manufacturing efficiency and produce structures that were impossible to mill in the past. This should lead to increased treatment options, greater comfort and cost reductions for patients. In order to meet growing demand, the Group is investing in Createch’s production capabilities and plans to share its technology with Straumann Group CADCAM centers in other regions.
Established in 2006 and located in Mendaro, Spain, Createch Medical is the Medical Division of the Egile XXI Corporation. The company employs a staff of 50 and specializes in the research, development and manufacture of high quality, innovative, implant-borne prosthetics. Its products, including CADCAM bridges, bars and abutments, are designed for a variety of implant systems and are sold mainly in Spain, Germany and other markets in Europe. Offering connections for more than 300 implant systems and a very broad range of materials, Createch is a one-stop shop for dental labs and achieved sales of approx. CHF 8 million in 2017.
About the Straumann Group
The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Straumann, Neodent, Medentika, ClearCorrect, Dental Wings, and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, digital and orthodontic solutions as well as biomaterials for applications in replacement, restorative, esthetic and preventative dentistry.
Headquartered in Basel, Switzerland, the Group currently employs approx. 5000 people worldwide and its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.